Acasă › Cancer pulmonar › Illinois › Waukegan
Studii clinice pentru Cancer pulmonar în Waukegan, IL
16 studii pentru Cancer pulmonar caută participanți în și în jurul orașului Waukegan (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
În curs de recrutareFaza 3
- AMG Libertyville - Oncology, Libertyville · La 8 mi distanță
- Condell Memorial Hospital, Libertyville · La 8 mi distanță
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- AMG Libertyville - Oncology, Libertyville · La 8 mi distanță
- Condell Memorial Hospital, Libertyville · La 8 mi distanță
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
În curs de recrutareFaza 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · La 7 mi distanță
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · La 10 mi distanță
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- AMG Libertyville - Oncology, Libertyville · La 8 mi distanță
- Condell Memorial Hospital, Libertyville · La 8 mi distanță
Empathic Communication Skills (ECS) Training
În curs de recrutareVoluntari sănătoși bineveniți
- Advocate Health Care Network, Libertyville · La 8 mi distanță
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
În curs de recrutareFaza 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · La 7 mi distanță
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · La 10 mi distanță
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
În curs de recrutareFaza 3
- Advocate Medical Group - Libertyville Oncology, Libertyville · La 8 mi distanță
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
În curs de recrutareFaza 1
- City of Hope - Chicago, Zion · La 6 mi distanță
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- City of Hope® Cancer Center Chicago, Zion · La 6 mi distanță
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Midwestern Regional Medical Center, Zion · La 6 mi distanță
- AMG Libertyville - Oncology, Libertyville · La 8 mi distanță
- Condell Memorial Hospital, Libertyville · La 8 mi distanță
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
În curs de recrutare
- Captain James A. Lovell Federal Health Care Center, North Chicago · La 3 mi distanță
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · La 7 mi distanță
- AMG Libertyville - Oncology, Libertyville · La 8 mi distanță
- Condell Memorial Hospital, Libertyville · La 8 mi distanță
- și încă 1
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · La 7 mi distanță
- AMG Libertyville - Oncology, Libertyville · La 8 mi distanță
- Condell Memorial Hospital, Libertyville · La 8 mi distanță
- și încă 1
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · La 7 mi distanță
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · La 10 mi distanță
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
În curs de recrutareFaza 2
- City of Hope at Chicago, Zion · La 6 mi distanță
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
În curs de recrutareStudiu observațional
- AMG Libertyville - Oncology, Libertyville · La 8 mi distanță
- Condell Memorial Hospital, Libertyville · La 8 mi distanță
Studii pentru Cancer pulmonar în alte orașe
- Houston, TX78 studii
- Boston, MA62 studii
- New York City, NY60 studii
- Los Angeles, CA45 studii
- Arlington, VA41 studii
- Washington, DC41 studii
- Chicago, IL41 studii
- Baltimore, MD40 studii
- Nashville, TN40 studii
- St. Louis, MO39 studii
- Columbus, OH37 studii
- Philadelphia, PA36 studii
Alte studii în Waukegan
- Cancer pulmonar cu celule non-pătrate16 studii
- Cancer de sân12 studii
- Colită ulcerativă7 studii
- Cancer renal (carcinom cu celule renale)7 studii
- Cancer ovarian6 studii
- Cancer metastatic6 studii
- Carcinom cu celule scuamoase de cap și gât6 studii
- Cancer colorectal6 studii
- Cancer de prostată6 studii
- Melanom5 studii
- Leucemie mieloasă acută5 studii
- Boala Crohn5 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.